Sarah Grasedieck
6PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 18, 2025
The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activation.Nadine Sperb, Irina A Maksakova, Leo Escano
|Mar 09, 2024
Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier.Sarah Grasedieck, Afsaneh Panahi, Matthew C Jarvis
|Oct 17, 2023
Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis.Andrew Wu, Ryan Yen, Sarah Grasedieck
|Aug 23, 2022
Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial.Ryan Yen, Sarah Grasedieck, Andrew Wu
|Mar 31, 2021
Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia.Xiaojia Niu, Katharina Rothe, Min Chen
|Nov 27, 2019
MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.Edith Schneider, Nicole Pochert, Christoph Ruess
Pageof 1
Frequent Collaborators
3 joint publications
Xiaoyan Jiang
2 joint publications
Sebastian Wiese
2 joint publications
Andrew Wu
2 joint publications
Connie J Eaves
2 joint publications
Florian Kuchenbauer
2 joint publications
Arefeh Rouhi
1 joint publications
Erik Delsing Malmberg
1 joint publications
Martin Hirst
1 joint publications
Xiaojia Niu
1 joint publications
Katharina Rothe
